Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until September, 2020.

  1. Definitive Studies For Use Of Galantamine As A Pre-Treatment Countermeasure Again

    SBC: Countervail Corporation            Topic: NINDS

    DESCRIPTION provided by applicant Fast Track SBIR Phase I and Phase II Exposure to centrally acting military nerve agents and organophosphorus OP pesticides are known to cause death and neurological damage Coupland Karalliedee Buckley Improved countermeasures to intoxication from these compounds are needed In numerous studies Albuquerque conducted at the University of Maryland School of Medicine U ...

    SBIR Phase II 2011 Department of Health and Human Services
  2. Drug and Alcohol Prevention for College Athletes

    SBC: Prevention Strategies, LLC            Topic: NIDA

    DESCRIPTION provided by applicant College student athletes are at increased risk of heavy alcohol use smokeless tobacco use and the use of performance enhancing substances as compared to non athlete college students Despite recent research underscoring the need for athlete tailored interventions there are no evidence based options for the prevention of substance use among college student at ...

    SBIR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health
  3. Novel Methods to Monitor Health Status and Clinical Laboratory Data: Portable Acquisition, Assessment, and Reporting

    SBC: Mimosa Acoustics Inc.            Topic: OSD09H26

    Mimosa Acoustics will develop a portable binaural audiological device, based on our successful HearID system. HearID is a clinical system for otoacoustic emission and middle-ear power analysis testing; it is FDA and CE-marked. The new system will have the ability to conduct a variety of audiological tests especially for use in hearing-conservation programs, including: flexible otoacoustic emission ...

    SBIR Phase II 2011 Department of DefenseDefense Health Program
  4. Keratin Biomaterials for Cranio-facial Tissue Engineering

    SBC: Keranetics, LLC            Topic: OSD09H10

    The majority of personnel injured in OIF/OEF have suffered blast injuries from IEDs. Blasts often cause cranio-facial trauma that is difficult to repair surgically. The current standard of care involves the placement of fixation devices and off label use of growth factor carriers. These strategies often require multiple surgical interventions creating a significant need for better technologies ...

    SBIR Phase II 2011 Department of DefenseDefense Health Program
  5. Spatiotemporally Controlled Keratin Biomaterial Delivery System for Functional Tissue Regeneration

    SBC: Keranetics, LLC            Topic: OSD10H03

    A principal approach in regenerative medicine is to stimulate or augment endogenous repair mechanisms that promote functional restoration of damaged or diseased tissues. When loss of significant volumes of multiple functionally integrated tissues occurs,

    SBIR Phase I 2011 Department of DefenseDefense Health Program
  6. EFFICIENT & EFFECTIVE MOBILE DATA CAPTURE IN AN ACRIN CLIN TRIAL ENVIRON

    SBC: ADVANCED DIGITAL SYSTEMS, INC.            Topic: N/A

    N/A

    SBIR Phase I 2004 Department of Health and Human Services
  7. Nanoliter Lab-on-a-Chip for Blood Diagnostics

    SBC: ADVANCED LIQUID LOGIC            Topic: N/A

    DESCRIPTION (provided by applicant): Large volumes of blood (milliliters) are required for diagnostics with large instruments, latrogenic blood loss or "bleeding into the laboratory" is an important reason for administration of small volume transfusions i

    SBIR Phase I 2004 Department of Health and Human Services
  8. Nanoliter Lab-on-a-chip for Protein Crystallization

    SBC: ADVANCED LIQUID LOGIC            Topic: N/A

    DESCRIPTION (provided by applicant): The human genome contains at least 30,000 unique open reading frames that may yield >100,000 polypeptide products. These products assemble into more than a million biologically relevant structures of interest per organ

    SBIR Phase I 2004 Department of Health and Human Services
  9. Radiation Protection Cancer Therapy with an SOD Mimetic

    SBC: AEOLUS PHARMACEUTICALS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Phase I. In the treatment of cancer, radiation therapy has been limited by the tolerance of the surrounding normal tissues, such as lung or mucosa. Until now, there have been no compounds available that protect the nor

    SBIR Phase II 2004 Department of Health and Human Services
  10. Innovation Tools for the Molecular Diagnosis of Cancer

    SBC: ALDERON BIOSCIENCES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Current treatment of cancer patients relies on establishing an accurate diagnosis using a complex combination of clinical and histopathological data but in some instances accurate diagnosis is difficult or impossible

    SBIR Phase I 2004 Department of Health and Human Services
US Flag An Official Website of the United States Government